Drug Price Transparency
Department of Health and Human Services (HHS) · April 29, 2026
A brief address from the Department of Health and Human Services explaining a forthcoming rule requiring real-time prescription price visibility for prescribers, the policy's intended benefits for patient affordability and prior authorization, and a call for vendors and providers to adopt the technology ahead of full implementation in 2027.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No related articles available for this source.
